Report

Identification of c-MYC as a Target of the APC Pathway

Science  04 Sep 1998:
Vol. 281, Issue 5382, pp. 1509-1512
DOI: 10.1126/science.281.5382.1509

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

The adenomatous polyposis coli gene (APC) is a tumor suppressor gene that is inactivated in most colorectal cancers. Mutations of APC cause aberrant accumulation of β-catenin, which then binds T cell factor–4 (Tcf-4), causing increased transcriptional activation of unknown genes. Here, the c-MYC oncogene is identified as a target gene in this signaling pathway. Expression of c-MYC was shown to be repressed by wild-type APC and activated by β-catenin, and these effects were mediated through Tcf-4 binding sites in the c-MYC promoter. These results provide a molecular framework for understanding the previously enigmatic overexpression of c-MYC in colorectal cancers.

  • * To whom correspondence should be addressed. E-mail: kinzlke{at}welchlink.welch.jhu.edu

View Full Text

Cited By...